ViewMind Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
20
ViewMind General Information
Description
Developer of neurotechnology solutions designed to objectively assess, monitor, and optimize brain function. The company offers non-invasive cognitive assessment, neurological monitoring, Alzheimer's disease detection, and cognitive training solutions using eye tracking, extended reality, oculometrics, and machine learning, enabling healthcare providers, pharmaceutical companies, and researchers to evaluate cognitive performance, monitor brain health, and measure treatment effectiveness.
Contact Information
Website
www.viewmind.comCorporate Office
- Post Office Box 1155
- Alpine, NJ 07620
- United States
Corporate Office
- Post Office Box 1155
- Alpine, NJ 07620
- United States
ViewMind Timeline
ViewMind Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Accelerator/Incubator | 17-Sep-2024 | Completed | Generating Revenue | |||
| 12. Later Stage VC (Series A) | 01-Jan-2024 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 27-Dec-2023 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 01-May-2023 | Completed | Generating Revenue | |||
| 9. Grant | 02-Jan-2023 | Completed | Generating Revenue | |||
| 8. Early Stage VC | 24-Nov-2022 | Completed | Generating Revenue | |||
| 7. Seed Round | 01-Aug-2021 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2020 | $5M | $1.06M | Completed | Clinical Trials - General | |
| 4. Grant | 04-Oct-2019 | $165K | $1.06M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ViewMind Comparisons
Industry
Financing
Details
ViewMind Competitors (17)
One of ViewMind’s 17 competitors is AEYE Health, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AEYE Health | Venture Capital-Backed | New York, NY | ||||
| machineMD | Venture Capital-Backed | Bern, Switzerland | ||||
| Innodem Neurosciences | Venture Capital-Backed | Montreal, Canada | ||||
| RetiSpec | Venture Capital-Backed | Toronto, Canada | ||||
| C. Light Technologies | Venture Capital-Backed | Cambridge, MA |
ViewMind Patents
ViewMind Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4578028-A1 | A method for training and quantifying specific motor skills and cognitive processes in persons by analysing oculomotor patterns w using a 3-d virtual reality device with embedded eye-tracking technology, specific visual stimuli, sensors to show the movement of limbs | Pending | 23-Aug-2022 | ||
| EP-4578028-A4 | A method for training and quantifying specific motor skills and cognitive processes in persons by analysing oculomotor patterns w using a 3-d virtual reality device with embedded eye-tracking technology, specific visual stimuli, sensors to show the movement of limbs | Pending | 23-Aug-2022 | ||
| WO-2024044242-A1 | A method for training and quantifying specific motor skills and cognitive processes in persons by analysing oculomotor patterns w using a 3-d virtual reality device with embedded eye-tracking technology, specific visual stimuli, sensors to show the movement of limbs | Inactive | 23-Aug-2022 | ||
| WO-2024026089-A2 | A method for identifying specific alterations in subjects with defined diseases analyzing oculomotor patterns when using specific visual stimuli, where a specific drug or treatment would enhance visual processing, cognitive performance and related brain activities | Inactive | 28-Jul-2022 | ||
| EP-4561443-A2 | Identifying disease-specific oculomotor patterns using visual stimuli, drug or treatment | Pending | 28-Jul-2022 | C07K16/2887 |
ViewMind Signals
ViewMind Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AgeTech Collaborative from AARP | Accelerator/Incubator | |||
| Alzheimers Drug Discovery Foundation | Not-For-Profit Venture Capital | |||
| Venturance Alternative Assets | Asset Manager | Minority | ||
| Eqwow Ventures | Impact Investing | Minority | ||
| Grupo Solum | Asset Manager | Minority |
ViewMind FAQs
-
When was ViewMind founded?
ViewMind was founded in 2018.
-
Where is ViewMind headquartered?
ViewMind is headquartered in Alpine, NJ.
-
What is the size of ViewMind?
ViewMind has 18 total employees.
-
What industry is ViewMind in?
ViewMind’s primary industry is Diagnostic Equipment.
-
Is ViewMind a private or public company?
ViewMind is a Private company.
-
What is ViewMind’s current revenue?
The current revenue for ViewMind is .
-
How much funding has ViewMind raised over time?
ViewMind has raised $8.06M.
-
Who are ViewMind’s investors?
AgeTech Collaborative from AARP, Alzheimers Drug Discovery Foundation, Venturance Alternative Assets, Eqwow Ventures, and Grupo Solum are 5 of 20 investors who have invested in ViewMind.
-
Who are ViewMind’s competitors?
AEYE Health, machineMD, Innodem Neurosciences, RetiSpec, and C. Light Technologies are some of the 17 competitors of ViewMind.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process